HomeEVOK • NASDAQ
Evoke Pharma Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 3.08M | 77.48% |
Operating expense | 4.34M | 38.04% |
Net income | -1.31M | 17.32% |
Net profit margin | -42.41 | 53.41% |
Earnings per share | -0.51 | 75.00% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.62M | 30.11% |
Total assets | 16.38M | 31.49% |
Total liabilities | 10.53M | 17.62% |
Total equity | 5.84M | — |
Shares outstanding | 2.02M | — |
Price to book | 1.25 | — |
Return on assets | -19.20% | — |
Return on capital | -28.07% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.31M | 17.32% |
Cash from operations | -997.51K | 61.33% |
Cash from investing | — | — |
Cash from financing | 25.00K | -99.67% |
Net change in cash | -972.51K | -119.59% |
Free cash flow | -702.37K | 66.83% |
Previous close
$3.61
Day range
$3.65 - $3.72
Year range
$1.94 - $12.32
Market cap
5.55M USD
Avg Volume
14.43K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2007
Headquarters
Website
Employees
3
